Cerevel Therapeutics Holdings, Inc. Stock
Equities
CERE
US15678U1280
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.19 USD | -0.26% | -0.85% | -0.50% |
May. 08 | Cerevel Therapeutics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 18 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 7.69B |
---|---|---|---|---|---|
Net income 2024 * | -456M | Net income 2025 * | -551M | EV / Sales 2024 * | - |
Net cash position 2024 * | 619M | Net cash position 2025 * | 690M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-16.9
x | P/E ratio 2025 * |
-15
x | Employees | 334 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 42.27% |
Latest transcript on Cerevel Therapeutics Holdings, Inc.
1 day | -0.26% | ||
1 week | -0.85% | ||
Current month | -1.22% | ||
1 month | +0.19% | ||
3 months | -1.61% | ||
6 months | +74.19% | ||
Current year | -0.50% |
Managers | Title | Age | Since |
---|---|---|---|
Ronald Renaud
CEO | Chief Executive Officer | 55 | 23-06-11 |
Director of Finance/CFO | 42 | 23-05-14 | |
N. Coles
CHM | Chairman | 63 | 18-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 19-05-31 | |
Douglas Giordano
BRD | Director/Board Member | 61 | 18-08-31 |
Ruth McKernan
BRD | Director/Board Member | 66 | 20-12-03 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.10% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 42.19 | -0.26% | 474,428 |
24-05-09 | 42.3 | +0.57% | 1,295,038 |
24-05-08 | 42.06 | -0.47% | 1,120,947 |
24-05-07 | 42.26 | -0.61% | 878,973 |
24-05-06 | 42.52 | -0.07% | 676,474 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.50% | 7.69B | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- CERE Stock